Effects of switching from efavirenz to raltegravir on endothelial function, bone mineral metabolism, inflammation, and renal function: a randomized, controlled trial.
Effects of switching from efavirenz to raltegravir on endothelial function, bone mineral metabolism, inflammation, and renal function: a randomized, controlled trial.
复制标题
DOI:
10.1097/qai.0b013e3182a97c39
复制
发表时间:
2013-11-01
期刊:
影响因子:
--
通讯作者:
Liu Z
中科院分区:
文献类型:
--
作者:
Gupta SK;Mi D;Moe SM;Dubé MP;Liu Z
We performed a randomized, controlled trial in 30 HIV-infected participants to either continue tenofovir/emtricitabine/efavirenz (Continuation Group) or switch to tenofovir/emtricitabine/raltegravir (Switch Group) for 24 weeks. There were no significant differences in the changes in flow-mediated dilation, 25(OH)vitamin D, or parathyroid hormone levels. Total cholesterol, high sensitivity C-reactive protein, serum alkaline phosphatase, sCD14 levels, and renal function significantly declined in the Switch Group compared to the Continuation Group; however, sCD163 levels significantly increased in the Switch Group. These findings suggest that raltegravir is not inherently more beneficial to endothelial function compared to efavirenz but may impact renal function and monocyte activation.
登录
查看更多内容
DOI:
10.1056/nejmoa1114248
发表时间:
2012-07-05
期刊:
The New England journal of medicine
影响因子:
--
作者:
Inker LA;Schmid CH;Tighiouart H;Eckfeldt JH;Feldman HI;Greene T;Kusek JW;Manzi J;Van Lente F;Zhang YL;Coresh J;Levey AS;CKD-EPI Investigators
通讯作者:
CKD-EPI Investigators
影响因子:
3.8
作者:
Asmuth, David M.;Ma, Zhong-Min;Pollard, Richard B.
通讯作者:
Pollard, Richard B.
影响因子:
1.5
作者:
Kristoffersen, Ulrik Sloth;Wiinberg, Niels;Kjaer, Andreas
通讯作者:
Kjaer, Andreas
影响因子:
5.2
作者:
Masia, Mar;Martinez, Esteban;Gutierrez, Felix
通讯作者:
Gutierrez, Felix
影响因子:
3.8
作者:
Martinez, Esteban;Larrousse, Maria;Gatell, Jose M.
通讯作者:
Gatell, Jose M.